Publication: Progeria: a perspective on potential drug targets and treatment strategies.
| dc.contributor.author | Benedicto, Ignacio | |
| dc.contributor.author | Chen, Xue | |
| dc.contributor.author | Bergo, Martin O | |
| dc.contributor.author | Andres, Vicente | |
| dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | es_ES |
| dc.contributor.funder | Agencia Estatal de Investigación (España) | es_ES |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | es_ES |
| dc.contributor.funder | Fundación La Marató TV3 | es_ES |
| dc.contributor.funder | Progeria Research Foundation | es_ES |
| dc.contributor.funder | Asociación Progeria Alexandra Peraut | es_ES |
| dc.contributor.funder | Center for Innovative Medicine (Karolinska Institutet) | es_ES |
| dc.contributor.funder | Swedish Research Council | es_ES |
| dc.contributor.funder | Comunidad de Madrid (España) | es_ES |
| dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
| dc.contributor.funder | Fundación ProCNIC | es_ES |
| dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | es_ES |
| dc.date.accessioned | 2022-11-21T10:51:36Z | |
| dc.date.available | 2022-11-21T10:51:36Z | |
| dc.date.issued | 2022 | |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | Work in the V.A. laboratory is supported by the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/ 10.13039/501100011033 (grant PID2019-108489RB-I00) with co-funding from the European Regional Development Fund (‘A way to build Europe’), Fundació la Marató TV3 (grant 202033), the Progeria Research Foundation (PRF) (award PRF 2019–77), and Asociación Progeria Alexandra Peraut. Work in the M.O.B. lab is supported by grants from the PRF, Center for Innovative Medicine (Karolinska Institutet), and the Swedish Research Council. I.B. is supported by the Comunidad Autónoma de Madrid (grant 2017-T1/BMD-5247). The CNIC is supported by the MCIN, the Instituto de Salud Carlos III, and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MCIN/AEI/ 10.13039/501100011033). | es_ES |
| dc.format.number | 5 | es_ES |
| dc.format.page | 393-399 | es_ES |
| dc.format.volume | 26 | es_ES |
| dc.identifier.citation | Expert Opin Ther Targets. 2022 May;26(5):393-399. | es_ES |
| dc.identifier.doi | 10.1080/14728222.2022.2078699 | es_ES |
| dc.identifier.e-issn | 1744-7631 | es_ES |
| dc.identifier.journal | Expert opinion on therapeutic targets | es_ES |
| dc.identifier.pubmedID | 35575136 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/15204 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Taylor & Francis | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/AEI/10.13039/501100011033 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-108489RB-I00 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/202033 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/2017-T1/BMD-5247 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CEX2020-001041-S | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/10.13039/501100011033 | es_ES |
| dc.relation.publisherversion | 10.1080/14728222.2022.2078699 | es_ES |
| dc.repisalud.institucion | CNIC | es_ES |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Fisiopatología Cardiovascular Molecular y Genética | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject.mesh | Progeria | es_ES |
| dc.subject.mesh | Animals | es_ES |
| dc.subject.mesh | Disease Models, Animal | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Mutation | es_ES |
| dc.title | Progeria: a perspective on potential drug targets and treatment strategies. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 2c0f32cd-37df-4f84-8525-e7b6dd84d087 | |
| relation.isAuthorOfPublication | 3bb85851-071a-490a-976b-c234983847a7 | |
| relation.isAuthorOfPublication.latestForDiscovery | 2c0f32cd-37df-4f84-8525-e7b6dd84d087 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Expert Opin Ther Targets 2022 May 26 Progeria a perspective on potential drug.pdf
- Size:
- 703.87 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo


